AstraZeneca Chief Puts Cancer Drugs Ahead of Deals

AstraZeneca Chief Executive Pascal Soriot is halfway through his plan to rebuild the company as a specialist in diseases such as cancer, heart ailments and diabetes, and megamergers definitely aren't on his agenda.



from WSJ.com: US Business http://ift.tt/QSL5HR

via IFTTT